Friday 13th September 2024 13:00 - 14:00 (BST)
Our panel of industry leaders came together for a deep dive into the current and future landscape of Generics, Branded Generics, and Biosimilars, exploring the pressing issues, opportunities, and emerging trends in the sector.
With a focus on the evolving political environment, we examined how the recent government changes could impact policy, procurement, and patient outcomes. The discussion covered the importance of continued engagement between the government and the off-patent sector, emphasising the vital role of generics and biosimilars in ensuring affordable healthcare.
Our speakers also addressed the challenges of maintaining a sustainable supply chain, highlighting the pressures caused by low-cost reimbursement models. The potential for biosimilars to increase patient access and reduce costs was another key topic, along with the future role of branded generics in hospital care.
13th Sep 2024 13:00 – 14:00 (BST)